Biotech

All Articles

' Medical instinct' led FDA experts to back Zevra's uncommon condition med

.Zevra Therapeutics' unusual disease medicine seems to be to become on the path to confirmation this...

Pfizer takes $230M reached after axing stopped working DMD genetics treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment failing has gone a $230 milli...

AC Immune views 'landmark' prospective in Alzheimer's medicine records

.After greater than two decades of focus on neurodegenerative ailments, Swiss biotech hvac Invulnera...

GSK loses ph. 2 HPV vaccination over shortage of best-in-class potential

.GSK has actually ditched a phase 2 individual papillomavirus (HPV) injection from its own pipe afte...

OS Treatments refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies are going to provide on the NYSE American inventory substitution this mo...

ALX's waning CD47 feedback rate sends out stock spiraling down

.ALX Oncology's period 2 stomach cancer action rate has actually compromised. After finding its own ...

Ionis centers eye health condition from intendeds of Roche-partnered possibility after records let down

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of requirements, cuing...

Biogen's CEO said no high-risk handle 2023. He prepares to be daring

.While Biogen's pharma peers are hunting for late-stage properties along with little bit of risk, ch...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has actually been a biotech looking for a pipe after it junked its own lead assets...

Biogen walks away from Denali Alzheimer's collab

.Biogen has restored civil rights to an early Alzheimer's health condition program to Denali Therape...